Cargando…

Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study

BACKGROUND: Liver transplantation (LT) is an effective therapy for acute-on-chronic liver failure (ACLF) but is limited by organ shortages. We aimed to identify an appropriate score for predicting the survival benefit of LT in HBV-related ACLF patients. METHODS: Hospitalized patients with acute dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Peng, Liang, Xi, Luo, Jinjin, Li, Jiaqi, Xin, Jiaojiao, Jiang, Jing, Shi, Dongyan, Lu, Yingyan, Hassan, Hozeifa Mohamed, Zhou, Qian, Hao, Shaorui, Zhang, Huafen, Wu, Tianzhou, Li, Tan, Yao, Heng, Ren, Keke, Guo, Beibei, Zhou, Xingping, Chen, Jiaxian, He, Lulu, Yang, Hui, Hu, Wen, Ma, Shiwen, Li, Bingqi, You, Shaoli, Xin, Shaojie, Chen, Yu, Li, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923183/ https://www.ncbi.nlm.nih.gov/pubmed/36793753 http://dx.doi.org/10.1016/j.lanwpc.2022.100638

Ejemplares similares

Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure
por: Liang, Xi, et al.
Publicado: (2023)

PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF
por: Li, Jiang, et al.
Publicado: (2022)

Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats
por: Hassan, Hozeifa M, et al.
Publicado: (2021)

Transcriptome Profiling Reveals Distinct Phenotype of Human Bone Marrow Mesenchymal Stem Cell-derived Hepatocyte-like cells
por: Shi, Dongyan, et al.
Publicado: (2020)

Characterisation of peripheral blood mononuclear cell microRNA in hepatitis B-related acute-on-chronic liver failure
por: Ding, Wenchao, et al.
Publicado: (2015)

Acute-on-chronic liver failure: far to go—a review
por: Luo, Jinjin, et al.
Publicado: (2023)

Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure
por: Zhou, Qian, et al.
Publicado: (2016)

MiRNA/mRNA network topology in hepatitis virus B-related liver cirrhosis reveals miR-20a-5p/340-5p as hubs initiating fibrosis
por: Yao, Heng, et al.
Publicado: (2022)

Prediction model of the progression of patients with acute deterioration of hepatitis B virus-related chronic liver disease to acute-on-chronic liver failure
por: Li, Chen, et al.
Publicado: (2018)

Combining Serum Cystatin C with Total Bilirubin Improves Short-Term Mortality Prediction in Patients with HBV-Related Acute-On-Chronic Liver Failure
por: Wan, Zhihong, et al.
Publicado: (2015)

MicroRNA Profile of Human Bone Marrow Mesenchymal Stem Cells during Hepatic Differentiation and Therapy
por: Jiang, Jing, et al.
Publicado: (2022)

Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment
por: Ju, Tao, et al.
Publicado: (2023)

Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model
por: Kan, Fangming, et al.
Publicado: (2017)

Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review
por: Hassan, Hozeifa Mohamed, et al.
Publicado: (2022)

Lower level of IL‐28A as a predictive index of the artificial liver support system in effective treatment of patients with HBV‐ACLF
por: Huang, Yandi, et al.
Publicado: (2022)

HBV infection-induced liver cirrhosis development in dual-humanised mice with human bone mesenchymal stem cell transplantation
por: Yuan, Lunzhi, et al.
Publicado: (2019)

RNA Profiling Analysis of the Serum Exosomes Derived from Patients with Chronic Hepatitis and Acute-on-chronic Liver Failure Caused By HBV
por: Chen, Jiajia, et al.
Publicado: (2020)

Reestablishment of Active Immunity against HBV Graft Reinfection after Liver Transplantation for HBV-Related End Stage Liver Disease
por: Lu, Shi-Chun, et al.
Publicado: (2014)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Correction: Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers
por: Furuta, Mayuko, et al.
Publicado: (2018)

Short hairpin RNA attenuates liver fibrosis by regulating the PPAR-γ and NF-κB pathways in HBV-induced liver fibrosis in mice
por: Ye, Lei, et al.
Publicado: (2020)

Association of Hepatitis B Virus Mutations of A1846T and C1913A/G With Acute-on-Chronic Liver Failure Development From Different Underlying Chronic Liver Diseases
por: Zhang, Aimin, et al.
Publicado: (2013)

Development of a Widely Applicable and Simple Prognostic Score for Patients with Acute-on-chronic Liver Failure
por: Yu, Zhenjun, et al.
Publicado: (2022)

The Effect of Artificial Liver Support System on Prognosis of HBV-Derived Hepatorenal Syndrome: A Retrospective Cohort Study
por: Sheng, Xinyu, et al.
Publicado: (2022)

Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection
por: van Buuren, Nicholas, et al.
Publicado: (2021)

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
por: Liu, Fangfang, et al.
Publicado: (2020)

Protective Role of α2HS-Glycoprotein in HBV-Associated Liver Failure
por: Dai, Xia-Hong, et al.
Publicado: (2011)

Pathological changes of liver one year later in CHB patients with negative HBV DNA
por: Shanshan, Wu, et al.
Publicado: (2019)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

Enhanced therapeutic effects of umbilical cord mesenchymal stem cells after prolonged treatment for HBV-related liver failure and liver cirrhosis
por: Jia, Yifan, et al.
Publicado: (2020)

Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo
por: Xu, Weiming, et al.
Publicado: (2022)

Effects of hepatic blood inflow on liver ultrastructure and regeneration after extensive liver resection in rats with cirrhosis
por: Jin, Wang-Xun, et al.
Publicado: (2018)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients
por: Mai, Rong-yun, et al.
Publicado: (2019)

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure
por: Li, Peng, et al.
Publicado: (2021)

Bioinformatic identification of key genes and pathways that may be involved in the pathogenesis of HBV-associated acute liver failure
por: Yang, Yalan, et al.
Publicado: (2018)

A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure
por: Zhu, Bing, et al.
Publicado: (2020)

Comparison of extracorporeal cellular therapy (ELAD(®)) vs standard of care in a randomized controlled clinical trial in treating Chinese subjects with acute-on-chronic liver failure
por: Duan, Zhongping, et al.
Publicado: (2018)

Isolation, culture, and delivery considerations for the use of mesenchymal stem cells in potential therapies for acute liver failure
por: Yang, Hui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_437sl9229k8plibd5q3c2uue93